FOSUTI : Fosfomycin Versus Standard of Care to Treat Children With Urinary Tract Infections
FOSUTI [1] is a pragmatic, multicentre, adaptive, non-inferiority trial to evaluate the safety, tolerability, efficacy and pharmacokinetics of oral fosfomycin to treat children with urinary tract infections (UTIs).
Authors
- Michelle L. Harrison (ORCID: https://orcid.org/0009-0005-4608-2659)
- Tom Snelling (ORCID: https://orcid.org/0000-0003-4670-0638)
- Marie J. Estcourt (ORCID: https://orcid.org/0000-0001-8403-6075)
- James Totterdell (ORCID: https://orcid.org/0000-0002-9459-2566)
- Robert Kelleghan (ORCID: https://orcid.org/0009-0008-2182-6801)
- Phoebe C. M. Williams
Institutions
- The University of Sydney (AU)
- Taronga Conservation Society Australia (AU)
- Sydney Children's Hospital (AU)
Publication Details
- Journal
- Journal of Paediatrics and Child Health
- Published
- 2026-09-08
- DOI
- https://doi.org/10.1111/jpc.70556
- Primary Topic
- Urinary Tract Infections Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00